{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T02:27:50Z","timestamp":1769048870061,"version":"3.49.0"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T00:00:00Z","timestamp":1762128000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T00:00:00Z","timestamp":1762128000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100018935","name":"Universit\u00e4tsklinikum Erlangen","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100018935","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Res Cardiol"],"published-print":{"date-parts":[[2026,2]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background and aims<\/jats:title>\n                    <jats:p>Sympathetic overactivation plays a critical role in the pathophysiology of various conditions, such as arterial hypertension, chronic kidney disease, coronary artery disease (CAD), diabetes, metabolic syndrome, and dyslipidemia. Initially developed for hypertension management, renal denervation (RDN) has also been associated with metabolic improvements. Preclinical studies in rodent models suggest that RDN may improve lipid profiles by reducing sympathetic activity. This study analyses the effect of RDN on lipid profiles in hypertensive patients with or without CAD.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      This analysis includes 122 hypertensive patients with (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200930) or without CAD (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200992). All patients underwent radiofrequency, ultrasound, or alcohol-injection-based RDN. Fasting lipid profile, including total cholesterol, triglyceride, low-density lipoprotein (LDL), high-density lipoprotein (HDL), and non-HDL levels was measured at baseline and 6\u00a0months after RDN in parallel to office and 24-h ambulatory blood pressure (BP).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Six months after RDN, the total cohort showed significant lipid profile improvements. The total cholesterol levels decreased by 10.3\u2009\u00b1\u200926.3\u00a0mg\/dL (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001), LDL by 7.0\u2009\u00b1\u200920.4\u00a0mg\/dL (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001), and triglycerides by 30.7\u2009\u00b1\u200969.4\u00a0mg\/dL (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001), while non-HDL cholesterol levels declined by 7.6\u2009\u00b1\u200926.3\u00a0mg\/dL (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.002). These changes were independent of BP reduction. In patients with CAD, total cholesterol levels declined by 21.7\u2009\u00b1\u200929.1\u00a0mg\/dL (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001), triglycerides by 40.7\u2009\u00b1\u200980.0\u00a0mg\/dL (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.009), LDL by 15.2\u2009\u00b1\u200922.0\u00a0mg\/dL (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001), HDL by 2.8\u2009\u00b1\u20094.7\u00a0mg\/dL (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.003), and non-HDL by 15.0\u2009\u00b1\u200934 .8\u00a0mg\/dL (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.021). Reductions in total cholesterol and LDL were greater in CAD than in non-CAD (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.011 and\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.006).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>We observed a significant improvement in lipid profiles in hypertensive patients with CAD after RDN. This improvement may represent an additive benefit of RDN in hypertensive patients with CAD.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Graphical Abstract<\/jats:title>\n                  <\/jats:sec>","DOI":"10.1007\/s00392-025-02768-4","type":"journal-article","created":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T15:12:55Z","timestamp":1762182775000},"page":"347-356","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Effect of renal denervation on the lipid profile in patients with or without coronary artery disease"],"prefix":"10.1007","volume":"115","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-9650-9220","authenticated-orcid":false,"given":"Venera","family":"Bytyqi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dennis","family":"Kannenkeril","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kristina","family":"Striepe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Axel","family":"Schmid","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marina V.","family":"Karg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Agnes","family":"Bosch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mario","family":"Schiffer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Uder","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roland E.","family":"Schmieder","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,11,3]]},"reference":[{"key":"2768_CR1","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1196\/annals.1410.064","volume":"1148","author":"M Esler","year":"2008","unstructured":"Esler M, Eikelis N, Schlaich M, Lambert G, Alvarenga M, Kaye D, El-Osta A, Guo L, Barton D, Pier C, Brenchley C, Dawood T, Jennings G, Lambert E (2008) Human sympathetic nerve biology: parallel influences of stress and epigenetics in essential hypertension and panic disorder. Ann N Y Acad Sci 1148:338\u2013348","journal-title":"Ann N Y Acad Sci"},{"key":"2768_CR2","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1161\/CIRCRESAHA.116.303604","volume":"116","author":"G Grassi","year":"2015","unstructured":"Grassi G, Mark A, Esler M (2015) The sympathetic nervous system alterations in human hypertension. Circ Res 116:976\u2013990","journal-title":"Circ Res"},{"key":"2768_CR3","doi-asserted-by":"publisher","first-page":"1478","DOI":"10.1097\/HJH.0000000000002839","volume":"39","author":"R Carnagarin","year":"2021","unstructured":"Carnagarin R, Kiuchi MG, Goh G, Adams L, Cohen N, Kavnoudias H, Gan SK, Van Schie G, Esler MD, Matthews VB, Schlaich MP (2021) Role of the sympathetic nervous system in cardiometabolic control: implications for targeted multiorgan neuromodulation approaches. J Hypertens 39:1478\u20131489","journal-title":"J Hypertens"},{"key":"2768_CR4","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1291\/hypres.29.839","volume":"29","author":"G Grassi","year":"2006","unstructured":"Grassi G (2006) Sympathetic overdrive and cardiovascular risk in the metabolic syndrome. Hypertens Res 29:839\u2013847","journal-title":"Hypertens Res"},{"key":"2768_CR5","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1111\/nyas.14217","volume":"1454","author":"R Carnagarin","year":"2019","unstructured":"Carnagarin R, Lambert GW, Kiuchi MG, Nolde JM, Matthews VB, Eikelis N, Lambert EA, Schlaich MP (2019) Effects of sympathetic modulation in metabolic disease. Ann N Y Acad Sci 1454:80\u201389","journal-title":"Ann N Y Acad Sci"},{"key":"2768_CR6","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1001\/jama.2023.0713","volume":"329","author":"M Azizi","year":"2023","unstructured":"Azizi M, Saxena M, Wang Y, Jenkins JS, Devireddy C, Rader F (2023) Endovascular ultrasound renal denervation to treat hypertension: the RADIANCE II randomized clinical trial. JAMA 329:651\u2013661","journal-title":"JAMA"},{"key":"2768_CR7","unstructured":"Bohm M, Kario K, Kandzari DE, Mahfoud F, Weber MA, Schmieder RE. Efficacy of catheter-based renal denervation in the absence of antihypertensive medications (SPYRAL HTN-OFF MED Pivotal): a multicentre"},{"key":"2768_CR8","doi-asserted-by":"publisher","DOI":"10.1097\/01.hjh.0000838544.56394.20","volume":"40","author":"F Mahfoud","year":"2022","unstructured":"Mahfoud F, Schmieder R, Schlaich M, Narkiewicz K, Ruilope L, Williams B, Fahy M, Mancia G, Bohm M (2022) Blood pressure reduction after catheter-based renal denervation in patients with cardiovascular disease in the global Symplicity registry. J Hypertens 40:e290","journal-title":"J Hypertens"},{"key":"2768_CR9","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2012.00010","volume":"3","author":"MP Schlaich","year":"2012","unstructured":"Schlaich MP, Hering D, Sobotka P, Krum H, Lambert GW, Lambert E, Esler MD (2012) Effects of renal denervation on sympathetic activation, blood pressure, and glucose metabolism in patients with resistant hypertension. Front Physiol 3:10","journal-title":"Front Physiol"},{"key":"2768_CR10","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1007\/s00592-023-02208-7","volume":"61","author":"E Koutra","year":"2024","unstructured":"Koutra E, Dimitriadis K, Pyrpyris N, Iliakis P, Fragkoulis C, Beneki E, Kasiakogias A, Tsioufis P, Tatakis F, Kordalis A, Tsiachris D, Aggeli K, Tsioufis K (2024) Unravelling the effect of renal denervation on glucose homeostasis: more questions than answers? Acta Diabetol 61:267\u2013280","journal-title":"Acta Diabetol"},{"key":"2768_CR11","doi-asserted-by":"publisher","first-page":"1940","DOI":"10.1161\/CIRCULATIONAHA.110.991869","volume":"123","author":"F Mahfoud","year":"2011","unstructured":"Mahfoud F, Schlaich M, Kindermann I, Ukena C, Cremers B, Brandt MC, Hoppe UC, Vonend O, Rump LC, Sobotka PA, Krum H, Esler M, B\u00f6hm M (2011) Effect of renal sympathetic denervation on glucose metabolism in patients with resistant hypertension: a pilot study. Circulation 123:1940\u20131946","journal-title":"Circulation"},{"key":"2768_CR12","doi-asserted-by":"crossref","unstructured":"Dimitriadis K, Iliakis P, Vakka A, Pyrpyris N, Pitsillidi A, Tsioufis P, Fragkoulis C, Hering D, Weil J, Kollias A, Konstantinidis D, Tsioufis K. Effects of sympathetic denervation in metabolism regulation: a novel approach for the treatment of MASLD? Cardiol Rev 2025.","DOI":"10.1097\/CRD.0000000000000850"},{"key":"2768_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/S0735-1097(20)34187-5","volume":"75","author":"L Zhuqing","year":"2020","unstructured":"Zhuqing L, Chengzhi L (2020) Renal denervation regulates lipid metabolism through AMPK\/PGC-1\u03b1 pathway in diet-induced obese rats. J Am Coll Cardiol 75:3560","journal-title":"J Am Coll Cardiol"},{"key":"2768_CR14","doi-asserted-by":"publisher","first-page":"2160","DOI":"10.1016\/S0140-6736(17)32281-X","volume":"390","author":"RR Townsend","year":"2017","unstructured":"Townsend RR, Mahfoud F, Kandzari DE, Kario K, Pocock S, Weber MA, Ewen S, Tsioufis K, Tousoulis D, Sharp ASP, Watkinson AF, Schmieder RE, Schmid A, Choi JW, East C, Walton A, Hopper I, Cohen DL, Wilensky R, Lee DP, Ma A, Devireddy CM, Lea JP, Lurz PC, Fengler K, Davies J, Chapman N, Cohen SA, DeBruin V, Fahy M, Jones DE, Rothman M, B\u00f6hm M, Aoki J, Batson B, B\u00f6hm M, Choi JW, Cohen DL, Dangas G, David S, Davies J, Devireddy CM, Kandzari D, Kario K, Lee DP, Lurz PC, Patel M, Patel K, Schmieder RE, Sharp ASP, Singh J, Tsioufis K, Walton A, Weber T, Weil J, Zeller T, Ziada K, Tanabe K, Wilkins R, Mahfoud F, East C, Wilensky R, Contreras J, Steigerwalt S, Chapman N, Lea JP, Reedus D, Hoshide S, Ma A, Fengler K, Svetkey L, Rao A, Schmid A, Watkinson AF, Brown A, Tousoulis D, Hopper I, Suppan M, Agdirlioglu T, Noory E, Chasen C (2017) Catheter-based renal denervation in patients with uncontrolled hypertension in the absence of antihypertensive medications (SPYRAL HTN-OFF MED): a randomised, sham-controlled, proof-of-concept trial. Lancet 390:2160\u20132170","journal-title":"Lancet"},{"key":"2768_CR15","doi-asserted-by":"publisher","first-page":"2335","DOI":"10.1016\/S0140-6736(18)31082-1","volume":"391","author":"M Azizi","year":"2018","unstructured":"Azizi M, Schmieder RE, Mahfoud F, Weber MA, Daemen J, Davies J, Basile J, Kirtane AJ, Wang Y, Lobo MD, Saxena M, Feyz L, Rader F, Lurz P, Sayer J, Sapoval M, Levy T, Sanghvi K, Abraham J, Sharp ASP, Fisher NDL, Bloch MJ, Reeve-Stoffer H, Coleman L, Mullin C, Mauri L (2018) Endovascular ultrasound renal denervation to treat hypertension (RADIANCE-HTN SOLO): a multicentre, international, single-blind, randomised, sham-controlled trial. Lancet 391:2335\u20132345","journal-title":"Lancet"},{"key":"2768_CR16","doi-asserted-by":"crossref","unstructured":"Azizi M, Sanghvi K, Saxena M, Gosse P, Reilly JP, Levy T, Rump LC, Persu A, Basile J, Bloch MJ, Daemen J, Lobo MD, Mahfoud F, Schmieder RE, Sharp ASP, Weber MA, Sapoval M, Fong P, Pathak A, Lantelme P, Hsi D, Bangalore S, Witkowski A, Weil J, Kably B, Barman NC, Reeve-Stoffer H, Coleman L, McClure CK, Kirtane AJ, RADIANCE-HTN investigators. Ultrasound renal denervation for hypertension resistant to a triple medication pill (RADIANCE-HTN TRIO): a randomised, multicentre, single-blind, sham-controlled trial. Lancet 2021;397:2476\u20132486.","DOI":"10.1016\/S0140-6736(21)00788-1"},{"key":"2768_CR17","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.ahj.2021.05.015","volume":"239","author":"F Mahfoud","year":"2021","unstructured":"Mahfoud F, Weber M, Schmieder RE, Lobo MD, Blankestijn PJ, Persu A, Fischell TA, Parise H, Pathak A, Kandzari DE (2021) Catheter-based alcohol-mediated renal denervation for the treatment of uncontrolled hypertension: design of two sham-controlled, randomized, blinded trials in the absence (TARGET BP OFF-MED) and presence (TARGET BP I) of antihypertensive medications. Am Heart J 239:90\u201399","journal-title":"Am Heart J"},{"key":"2768_CR18","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1016\/j.jcin.2019.10.048","volume":"13","author":"F Mahfoud","year":"2020","unstructured":"Mahfoud F, Renkin J, Sievert H, Bertog S, Ewen S, B\u00f6hm M, Lengel\u00e9 J-P, Wojakowski W, Schmieder R, van der Giet M, Parise H, Haratani N, Pathak A, Persu A (2020) Alcohol-mediated renal denervation using the Peregrine system infusion catheter for treatment of hypertension. JACC Cardiovasc Interv 13:471\u2013484","journal-title":"JACC Cardiovasc Interv"},{"key":"2768_CR19","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.pharmthera.2010.02.002","volume":"126","author":"GW Lambert","year":"2010","unstructured":"Lambert GW, Straznicky NE, Lambert EA, Dixon JB, Schlaich MP (2010) Sympathetic nervous activation in obesity and the metabolic syndrome\u2014causes, consequences and therapeutic implications. Pharmacol Ther 126:159\u2013172","journal-title":"Pharmacol Ther"},{"key":"2768_CR20","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/S0895-7061(96)00303-2","volume":"10","author":"K Masuo","year":"1997","unstructured":"Masuo K, Mikami H, Ogihara T, Tuck ML (1997) Sympathetic nerve hyperactivity precedes hyperinsulinemia and blood pressure elevation in a young, nonobese Japanese population. Am J Hypertens 10:77\u201383","journal-title":"Am J Hypertens"},{"key":"2768_CR21","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/341583","volume":"2015","author":"AA Thorp","year":"2015","unstructured":"Thorp AA, Schlaich MP (2015) Relevance of sympathetic nervous system activation in obesity and metabolic syndrome. J Diabetes Res 2015:341583","journal-title":"J Diabetes Res"},{"key":"2768_CR22","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1093\/eurheartj\/ehu467","volume":"36","author":"FH Messerli","year":"2015","unstructured":"Messerli FH, Bangalore S, Schmieder RE (2015) Wilder\u2019s principle: pre-treatment value determines post-treatment response. Eur Heart J 36:576\u2013579","journal-title":"Eur Heart J"},{"key":"2768_CR23","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1080\/080370598438474","volume":"3","author":"A Lanfranchi","year":"1998","unstructured":"Lanfranchi A, Spaziani D, Seravalle G, Turri C, Dell\u2019Oro R, Grassi G, Mancia G (1998) Sympathetic control of circulation in hypertension and congestive heart failure. Blood Press Suppl 3:40\u201345","journal-title":"Blood Press Suppl"},{"key":"2768_CR24","doi-asserted-by":"publisher","first-page":"1979","DOI":"10.1097\/00004872-199816121-00019","volume":"16","author":"G Grassi","year":"1998","unstructured":"Grassi G (1998) Role of the sympathetic nervous system in human hypertension. J Hypertens 16:1979\u20131987","journal-title":"J Hypertens"},{"key":"2768_CR25","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1161\/01.HYP.0000242642.42177.49","volume":"48","author":"M Esler","year":"2006","unstructured":"Esler M, Straznicky N, Eikelis N, Masuo K, Lambert G, Lambert E (2006) Mechanisms of sympathetic activation in obesity-related hypertension. Hypertension 48:787\u2013796","journal-title":"Hypertension"},{"issue":"41","key":"2768_CR26","first-page":"111","volume":"2020","author":"Mach F, Baigent C, Catapano AL, Koskinas KC, Casula M, Badimon L, Chapman MJ, De Backer GG, Delgado V, Ference BA, Graham IM, Halliday A, Landmesser U, Mihaylova B, Pedersen TR, Riccardi G, Richter DJ, Sabatine MS, Taskinen M-R, Tokgozoglu L, Wiklund O, ESC Scientific Document Group","year":"2019","unstructured":"Mach F, Baigent C, Catapano AL, Koskinas KC, Casula M, Badimon L, Chapman MJ, De Backer GG, Delgado V, Ference BA, Graham IM, Halliday A, Landmesser U, Mihaylova B, Pedersen TR, Riccardi G, Richter DJ, Sabatine MS, Taskinen M-R, Tokgozoglu L, Wiklund O, ESC Scientific Document Group (2019) ESC\/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk. Eur Heart J 2020(41):111\u2013188","journal-title":"Eur Heart J"},{"key":"2768_CR27","doi-asserted-by":"crossref","unstructured":"Ray KK, Molemans B, Schoonen WM, Giovas P, Bray S, Kiru G, Murphy J, Banach M, De Servi S, Gaita D, Gouni-Berthold I, Hovingh GK, Jozwiak JJ, Jukema JW, Kiss RG, Kownator S, Iversen HK, Maher V, Masana L, Parkhomenko A, Peeters A, Clifford P, Raslova K, Siostrzonek P, Romeo S, Tousoulis D, Vlachopoulos C, Vrablik M, Catapano AL, Poulter NR, DA VINCI study. EU-wide cross-sectional observational study of lipid-modifying therapy use in secondary and primary care: the DA VINCI study. Eur J Prev Cardiol 2021;28:1279\u20131289.","DOI":"10.1093\/eurjpc\/zwaa047"},{"key":"2768_CR28","doi-asserted-by":"crossref","unstructured":"Ray KK, Haq I, Bilitou A, Manu MC, Burden A, Aguiar C, Arca M, Connolly DL, Eriksson M, Ferri\u00e8res J, Laufs U, Mostaza JM, Nanchen D, Rietzschel E, Strandberg T, Toplak H, Visseren FLJ, Catapano AL, SANTORINI Study Investigators. Treatment gaps in the implementation of LDL cholesterol control among high- and very high-risk patients in Europe between 2020 and 2021: the multinational observational SANTORINI study. Lancet Reg Health Eur 2023;29:100624.","DOI":"10.1016\/j.lanepe.2023.100624"},{"key":"2768_CR29","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.athplu.2022.07.024","volume":"50","author":"I Gouni-Berthold","year":"2022","unstructured":"Gouni-Berthold I, Schaper F, Schatz U, Tabbert-Zitzler A, Fraass U, Sauer S, Ray KK (2022) Low-density lipoprotein cholesterol goal attainment in Germany: results from the DA VINCI study. Atheroscler Plus 50:10\u201316","journal-title":"Atheroscler Plus"},{"key":"2768_CR30","doi-asserted-by":"publisher","DOI":"10.1016\/S0895-7061(01)02236-1","volume":"14","author":"M Esler","year":"2001","unstructured":"Esler M (2001) Sympathetic nervous system and insulin resistance: from obesity to diabetes. Am J Hypertens 14:S304\u2013S309","journal-title":"Am J Hypertens"},{"key":"2768_CR31","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1038\/hr.2010.35","volume":"33","author":"K Masuo","year":"2010","unstructured":"Masuo K, Lambert GW, Esler MD, Rakugi H, Ogihara T, Schlaich MP (2010) The role of sympathetic nervous activity in renal injury and end-stage renal disease. Hypertens Res 33:521\u2013528","journal-title":"Hypertens Res"},{"key":"2768_CR32","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1002\/cbf.1047","volume":"22","author":"FR Carre\u00f1o","year":"2004","unstructured":"Carre\u00f1o FR, Seelaender MCL (2004) Liver denervation affects hepatocyte mitochondrial fatty acid transport capacity. Cell Biochem Funct 22:9\u201317","journal-title":"Cell Biochem Funct"},{"key":"2768_CR33","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1093\/ajh\/hps016","volume":"26","author":"E Lambert","year":"2013","unstructured":"Lambert E, Straznicky N, Sari CI, Eikelis N, Hering D, Head G, Dixon J, Esler M, Schlaich M, Lambert G (2013) Dyslipidemia is associated with sympathetic nervous activation and impaired endothelial function in young females. Am J Hypertens 26:250\u2013256","journal-title":"Am J Hypertens"},{"key":"2768_CR34","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.1038\/hr.2010.137","volume":"33","author":"J Lewandowski","year":"2010","unstructured":"Lewandowski J, Si\u0144ski M, Bidiuk J, Abramczyk P, Dobosiewicz A, Ciarka A, Gaciong Z (2010) Simvastatin reduces sympathetic activity in men with hypertension and hypercholesterolemia. Hypertens Res 33:1038\u20131043","journal-title":"Hypertens Res"},{"key":"2768_CR35","doi-asserted-by":"publisher","first-page":"369","DOI":"10.3389\/fphys.2017.00369","volume":"8","author":"N Eikelis","year":"2017","unstructured":"Eikelis N, Hering D, Marusic P, Duval J, Hammond LJ, Walton AS, Lambert EA, Esler MD, Lambert GW, Schlaich MP (2017) The effect of renal denervation on plasma adipokine profile in patients with treatment resistant hypertension. Front Physiol 8:369","journal-title":"Front Physiol"},{"key":"2768_CR36","doi-asserted-by":"publisher","DOI":"10.3390\/jcm12062114","author":"B Czerwie\u0144ska","year":"2023","unstructured":"Czerwie\u0144ska B, Lelek M, Gojowy D, Surma S, Mizia-Stec K, Wi\u0119cek A, Adamczak M (2023) Effect of renal denervation on the plasma adiponectin concentration in patients with resistant hypertension. J Clin Med. https:\/\/doi.org\/10.3390\/jcm12062114","journal-title":"J Clin Med"},{"key":"2768_CR37","doi-asserted-by":"publisher","DOI":"10.3390\/ijms19113447","volume":"19","author":"C-F Cheng","year":"2018","unstructured":"Cheng C-F, Ku H-C, Lin H (2018) Pgc-1\u03b1 as a pivotal factor in lipid and metabolic regulation. Int J Mol Sci 19:3447","journal-title":"Int J Mol Sci"},{"key":"2768_CR38","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1007\/s00592-020-01659-6","volume":"58","author":"Z Zhang","year":"2021","unstructured":"Zhang Z, Liu K, Xiao S, Chen X (2021) Effects of catheter-based renal denervation on glycemic control and lipid levels: a systematic review and meta-analysis. Acta Diabetol 58:603\u2013614","journal-title":"Acta Diabetol"},{"key":"2768_CR39","doi-asserted-by":"publisher","first-page":"1599","DOI":"10.1161\/CIRCULATIONAHA.124.069709","volume":"150","author":"D Vukadinovi\u0107","year":"2024","unstructured":"Vukadinovi\u0107 D, Lauder L, Kandzari DE, Bhatt DL, Kirtane AJ, Edelman ER, Schmieder RE, Azizi M, B\u00f6hm M, Mahfoud F (2024) Effects of catheter-based renal denervation in hypertension: a systematic review and meta-analysis. Circulation 150:1599\u20131611","journal-title":"Circulation"}],"container-title":["Clinical Research in Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00392-025-02768-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00392-025-02768-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00392-025-02768-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T11:38:52Z","timestamp":1768995532000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00392-025-02768-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,3]]},"references-count":39,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["2768"],"URL":"https:\/\/doi.org\/10.1007\/s00392-025-02768-4","relation":{},"ISSN":["1861-0684","1861-0692"],"issn-type":[{"value":"1861-0684","type":"print"},{"value":"1861-0692","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,3]]},"assertion":[{"value":"28 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}